New Scenarios in Liver Transplantation for Hepatocellular Carcinoma
Liver International · 2025-04 · 45 (4)
DOI: 10.1111/liv.16142 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Liver International, online erschienen am 04.11.2024. Verfasst von Ezequiel Mauro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, ICMDM, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Transplantation, Liver Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and Aims Despite liver transplantation (LT) is considered the optimal treatment for hepatocellular carcinoma (HCC), particularly in patients with impaired liver function, the shortage of donors has forced the application of very restrictive criteria for selecting ideal candidates for whom LT can offer the best outcome. With the evolving LT landscape due to the advent of direct‐acting antivirals (DAAs) and the steady increase in donors, major efforts have been made to expand the transplant eligibility criteria for HCC. In addition, the emergence of immune checkpoint inhibitors (ICIs) for the treatment of HCC, with demonstrated efficacy in earlier stages, has revolutionized the therapeutic approach for these patients, and their integration in the setting of LT is challenging. Management of immunological compromise from ICIs, including the wash‐out period before LT and post‐LT immunosuppression adjustments, is crucial to balance the risk of graft rejection against HCC recurrence. Additionally, the effects of increased immunosuppression on non‐hepatic complications must be understood to prevent them from becoming obstacles to long‐term OS. Methods and Results In this review, we will evaluate the emerging evidence and its implications for the future of LT in HCC. Addressing these novel challenges and opportunities, while integrating the current clinical evidence with predictive algorithms, would ensure a fair balance between individual patient needs and the overall population benefit in the LT system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, ICMDM, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
- Department of Hepatology and Liver Transplantation, Hospital Universitario Reina Sofía, Universidad de Córdoba, IMIBIC, CIBERehd, Córdoba, Spain.
- Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK.
- Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
- Liver Transplant Unit, Liver Unit, ICMDM, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
ORCID-Profile: Ezequiel Mauro, Manuel Rodríguez-Perálvarez, Antonio D'Alessio, Gonzalo Crespo, Federico Piñero, Eleonora De Martin, Jordi Colmenero, David James Pinato, Alejandro Forner
Zitieren
APA
Mauro, E., Rodríguez-Perálvarez, M., D'Alessio, A., Crespo, G., Piñero, F., De Martin, E., Colmenero, J., Pinato, D. J., & Forner, A. (2025). New Scenarios in Liver Transplantation for Hepatocellular Carcinoma. Liver International, 45(4). https://doi.org/10.1111/liv.16142
Vancouver
Mauro E, Rodríguez-Perálvarez M, D'Alessio A, Crespo G, Piñero F, De Martin E, et al. New Scenarios in Liver Transplantation for Hepatocellular Carcinoma. Liver International. 2025;45(4). doi:10.1111/liv.16142
BibTeX
@article{Mauro2025,
author = {Mauro, Ezequiel and Rodríguez-Perálvarez, Manuel and D'Alessio, Antonio and Crespo, Gonzalo and Piñero, Federico and De Martin, Eleonora and Colmenero, Jordi and Pinato, David James and Forner, Alejandro},
title = {New Scenarios in Liver Transplantation for Hepatocellular Carcinoma},
journal = {Liver International},
year = {2025},
volume = {45},
number = {4},
doi = {10.1111/liv.16142}
}
EUVIMED